Age-Based (<65 vs ≥65 years) Incidence of Infections and Serious Infections with Tofacitinib Versus Biological DMARDs in Rheumatoid Arthritis Clinical Trials and the US Corrona RA Registry
Ann Rheum Dis 2020; DOI: 10.1136/annrheumdis-2020-218992
View and download slide summaries of the latest original articles focusing on therapies in immune-mediated inflammatory diseases including rheumatology, dermatology, and gastroenterology. All materials produced by the team are subsequently reviewed and approved by individual Steering Committee members.
Ann Rheum Dis 2020; DOI: 10.1136/annrheumdis-2020-218992
Annals of the Rheumatic Diseases, May 2020
Arthritis Care Res (Hoboken) 2020;72(8):1112-1121
Nat Rev Rheumatol 2020 doi.org/10.1038/s41584-020-0451-z
Lancet Rheumatol 2020;2:e347–57
Clin Exp Rheumatol . Jul-Aug 2020;38(4):732-741. Epub 2020 May 20.
RMD Open 2020;6:e001095
Drug Saf. 2020;43:379-392
Rheumatol Ther . 2019 Dec;6(4):503-520. doi: 10.1007/s40744-019-00167-6. Epub 2019 Aug 13.
Int J Rheum Dis . 2020 Jan;23(1):65-73. doi: 10.1111/1756-185X.13748.